Brief: Bellus Health Provides Update On Its Chronic Cough Drug Candidate Blu-5937, Reports Qtrly Results

BELLUS Health

08/05/2019 22:57

May 8 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH PROVIDES UPDATE ON ITS CHRONIC COUGH DRUG
CANDIDATE BLU-5937 AND REPORTS FINANCIAL AND OPERATING RESULTS
FOR THE FIRST QUARTER ENDED MARCH 31, 2019
    * BELLUS HEALTH INC - COMPANY CONCLUDED QUARTER WITH CASH,
CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS TOTALLING $45.4 MILLION
    * BELLUS HEALTH INC - HAS ENOUGH CAPITAL TO FUND ITS
OPERATIONS
INTO Q1 2021
    * BELLUS HEALTH INC - QTRLY LOSS PER SHARE $0.03

Source text for Eikon:  ID:nBw5jppZJa 
Further company coverage:  BLU.TO 

 ((Briefs@thomsonreuters.com;))